Provided by Tiger Trade Technology Pte. Ltd.

SBP GROUP

5.485
-0.190-3.35%
Volume:82.18M
Turnover:461.49M
Market Cap:102.48B
PE:36.09
High:5.865
Open:5.560
Low:5.475
Close:5.675
52wk High:8.335
52wk Low:4.136
Shares:18.68B
HK Float Shares:18.68B
Volume Ratio:1.89
T/O Rate:0.44%
Dividend:0.12
Dividend Rate:2.24%
EPS(LYR):0.152
ROE:14.07%
ROA:7.51%
PB:2.69
PE(LYR):36.09
PS:2.60

Loading ...

China Biopharmaceuticals Advances Novel HER2-Targeting Bispecific ADC Toward Market Approval

Stock News
·
Sep 16

Sino Biopharmaceutical - China Cde Accepts New Drug Application for Tqb2102 Injection

THOMSON REUTERS
·
Sep 16

Sino Biopharmaceutical Stock Slips 1.0% in Hong Kong

Dow Jones
·
Sep 15

Sino Biopharmaceutical Stock Advances 4.3% in Hong Kong, Outperforms Competitors

Dow Jones
·
Sep 14

Big Pharma is Pouring Billions into China's Biotechs

Dow Jones
·
Sep 14

Sino Biopharmaceutical Climbs on Plan to Raise Stake in Core Unit

Reuters
·
Sep 14

Goldman Sachs Lifts SBP Group Target Price to HK$9.07, Reaffirms Buy Rating

Stock News
·
Sep 14

HK Stocks in Focus: Innovative Drug Sector Surges on WCLC Data Boost, Analysts See Value After Pullback

Stock News
·
Sep 14

Movement Alert|SBP GROUP Rises 3.14% in Regular Trading, Plans RMB 4.48 Billion Acquisition to Raise CT Tianqing Stake to 65%

Market Focus
·
Sep 14

Movement Alert|SBP GROUP Rises 3.43% at Open, Plans RMB 4.48 Billion Acquisition to Boost CT Tianqing Stake to 65%

Market Focus
·
Sep 14

Biopharma Giant's HK$4.48 Billion Stake Purchase Highlights Key Hong Kong Stock Market Announcements

Stock News
·
Sep 14

Crude Supply Shock Looms as Saudi Pipeline Outage Threatens 4% of Global Output

Stock News
·
Sep 14

Sino Biopharm Secures Deal to Up Stake in CT Tianqing

MT Newswires Live
·
Sep 11

Sino Biopharmaceutical - Sbp Group to Buy 5% Equity Interest in Ct Tianqing for Rmb4.48 Bln at 19X Ltm P/E

THOMSON REUTERS
·
Sep 11

Movement Alert|SBP GROUP Falls 3.19% in Regular Trading, Trading at HK$5.3

Market Focus
·
Sep 11

Sino Biopharmaceutical Stock Slides 2.3% in Hong Kong

Dow Jones
·
Sep 10

Sino Biopharmaceutical Stock Slides 4.0% in Hong Kong, Underperforms Competitors

Dow Jones
·
Sep 09

UBS: Mixed First-Half Results for Chinese Pharma Stocks, Names Simcere as Top Pick

Stock News
·
Sep 09

Movement Alert|SBP GROUP Declines 3.08% in Regular Trading, Trading at 5.67 HKD

Market Focus
·
Sep 09

SBP Group Unveils Preclinical Findings for Oral STAT6 Degrader TQH5528 at ERS 2026

Stock News
·
Sep 08